PathMaker Neurosystems is opening up a new era of non-invasive treatment of serious neurological disorders based on recent advances in multi-site neuromodulation that enable the safe and non-invasive treatment of patients with Spasticity and ALS. Our proprietary technology is built upon the pioneering work of Prof. Zaghloul Ahmed (CUNY) and our scientific advisors. With offices in Boston and New York, we are rapidly moving  our clinical-stage programs forward to commercialization with a veteran team of medical device executives.